ARTICLE | Company News
Alseres, Navidea deal
June 8, 2015 7:00 AM UTC
The partners terminated a 2012 deal granting Navidea exclusive, worldwide rights to develop and commercialize Altropane ( NAV5001). Navidea will be eligible to receive a milestone payment upon FDA ap...